Author/Authors :
Ziaee، Seyyed Amir Mohsen نويسنده , , Sarhangnejad، Reza نويسنده Urology and Nephrology Research Center, ShahidLabbafinejad Medical Center, ShahidBeheshti University of Medical Sciences, Tehran, Iran , , Abolghasemi، Hassan نويسنده , , Eshghi، Peyman نويسنده , , Radfar، Mohammad Hadi نويسنده , , Ahanian، Ali نويسنده , , Kardoust Parizi، Mehdi نويسنده Urology and Nephrology Research Center; Department of Urology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Teh , , Amirizadeh، Nasser نويسنده Urology and Nephrology Research Center, No. 103, 9th Boustan St., Pasdaran Ave., Tehran , , Nouralizadeh، Akbar نويسنده Urology and Nephrology Research Center, No.103, 9th Boustan St., Pasdaran Ave., Tehran ,
Abstract :
Purpose: To evaluate the efficacy of autologous single-donor fibrin glue after tubeless percutaneous
nephrolithotomy (PCNL).
Materials and Methods: Forty-three patients were planned for tubeless PCNL in a prospective
cohort study and randomized in two groups with or without using fibrin glue. Randomization
method was based on the computer-generated random numbers.
Results: Transfusion, urinary leakage, or major complications were found in neither of the
groups. There was no difference between two groups in stone free rate (P = .53), and changes
in hemoglobin (P = .61) and serum creatinine (P = .63) level.
Conclusion: Although autologous fibrin glue did not play any significant role in improving
results or decreasing complications after tubeless PCNL in our study, its use was safe and did
not increase complications.
